scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/0092-8674(91)90644-E |
P698 | PubMed publication ID | 1988152 |
P2093 | author name string | McCune JM | |
P2860 | cites work | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 |
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV | Q15787 |
P304 | page(s) | 351-363 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | HIV-1: the infective process in vivo | |
P478 | volume | 64 |
Q44818812 | A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein |
Q73358372 | A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci |
Q24300123 | A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells |
Q36632636 | A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. |
Q36646025 | Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors |
Q35833602 | Alterations of thymus cortical epithelium and interdigitating dendritic cells but no increase of thymocyte cell death in the early course of simian immunodeficiency virus infection |
Q41504287 | Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains |
Q36925272 | Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. |
Q40007089 | Direct detection of proviral gag segment of human immunodeficiency virus in peripheral blood lymphocytes by colorimetric PCR assay as a clinical laboratory tool applied to different at-risk populations |
Q36362732 | Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1 |
Q36651742 | Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. |
Q37083535 | Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load |
Q40056665 | Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions |
Q36486560 | Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein |
Q40476400 | Gene therapeutic agents: The use of ribozymes, antisense, and RNA decoys for HIV-1 infection |
Q34743627 | Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease |
Q45305157 | HIV induces thymus depletion in vivo |
Q40893509 | HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract |
Q46062714 | HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo |
Q45784829 | Histopathological changes in lymph nodes of cats experimentally infected with the feline immunodeficiency virus (FIV). |
Q40407802 | Human T cell transcription factor GATA-3 stimulates HIV-1 expression |
Q36030112 | Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication |
Q28282470 | Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition |
Q33854319 | Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism |
Q35363070 | Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. |
Q46120844 | Immunoglobulin V H 3 Gene Products: Natural Ligands for HIV gp120 |
Q34409007 | Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group |
Q45737944 | Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes |
Q35403061 | Mechanism of action of regulatory proteins encoded by complex retroviruses |
Q40395451 | Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV. |
Q37019281 | Preclinical Evaluation of Human Hematolymphoid Function in the SCID-hu Mouse |
Q45860499 | Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. The Italian Register for Human Immunodeficiency Virus Infection in Children |
Q34796157 | Prognostic value of immunological data, in vitro antibody production, and virus culture in vertical infection with HIV-1 |
Q41638947 | Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus |
Q24651506 | Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors |
Q36420782 | Replication and regulation of primate foamy viruses |
Q30467457 | Retroviruses and cancer: models for cancer in animals and humans |
Q35833626 | Revenge of the microbes. Superantigens of the T and B cell lineage |
Q35137965 | Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. |
Q33851415 | Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus |
Q44413561 | Serum containing ovine IgG2 antibody specific for maedi visna virus envelope glycoprotein mediates antibody dependent cellular cytotoxicity |
Q34961807 | Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses |
Q41656290 | T cell turnover in HIV-1 disease |
Q41546977 | The SCID-hu mouse as a model for HIV-1 infection |
Q33942992 | The dynamics of CD4+ T-cell depletion in HIV disease |
Q40662335 | The molecular biology of HIV. Insights into pathogenesis and targets for therapy. |
Q37532559 | The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity |
Q40467649 | The vpr Regulatory Gene of HIV |
Q36653688 | Transplacental transmission of a leukemogenic murine leukemia virus. |
Q36697615 | Viral infection of the thymus |
Search more.